Sensus Healthcare, Inc. (SRTS) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Grand Canyon Education places CFO on leave amid stock trade probe
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
Sensus Healthcare (SRTS) PT Raised to $9 at Maxim Group
February 2, 2018 7:36 AM ESTMaxim Group raised its price target on Sensus Healthcare (NASDAQ: SRTS) to $9.00 (from $7.50) while maintaining a Buy rating.
Analyst Anthony Vendetti cited Better-than-Expected 4Q17 Results and 510(k) Submissions for Two New Products.
... More